MR Number;Product Name;Domain;Active substances;Pharmaceutical Form;Application Type Level 1;Application Type Level 2;Application Type Level 3;Application Type Level 4;Application Type Level 5;Marketing Authorization Holder;RMS;CMS;Date of outcome;Date of last update;ATC-Code;Strength;SPC Url;Par Url;Final Labelling Url;Final PL Url;Finalised Product Information Url
NL/H/0809/001 ;Flecaïnideacetaat 50 mg;Human;flecainide acetate 50 mg;Tablet;Abridged;Initial Application;Generic;Chemical Substance;Prescription Only;Hexal AG Holzkirchen Germany;Netherlands;DE - Flecainid-1 A Pharma;01.08.2006;10.02.2013;C01BC04-Flecainide;50mg;http://db.cbg-meb.nl/mri/spc/nlh-0809-001.pdf;http://db.cbg-meb.nl/mri/par/nlh-0809-001-002.pdf;;;